Back to AZNView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Chronic Obstructive Pulmonary Disease
View Full LandscapeDrug Information
Target Indication
Chronic Obstructive Pulmonary Disease
Clinical Trial
NCT02796677Last updated: 11/15/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Aclidinium bromide (AB)Phase 3
Chronic Obstructive Pulmonary Disease
AZD6234Phase 3
Obesity/Overweight
Formoterol fumarate (FF)Phase 3
Chronic Obstructive Pulmonary Disease
AZD1152Phase 3
Acute Myeloid Leukemia
Niraparib plus Abiraterone acetate plus PrednisonePhase 3
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
